Healthcare AI Ops & Oversight

The executive brief on AI in healthcare operations.

Will Your Clinical AI Refuse an Unsafe Instruction?

A correct answer is not enough when the request itself puts patient safety at risk.

Safety reminders reduced potentially harmful choices from 16.6% to 10.1% in a study of clinical AI instructions. They did not eliminate those choices. The executive question is not simply whether a model knows the right answer. It is whether the system will challenge the wrong request. Communications Medicine.

We recommend making that behavior an explicit approval requirement for any proposed workflow where an AI response could influence clinical action. Ask for evidence of appropriate refusal, clarification, and escalation before expanding access or granting additional permissions.

What the Study Actually Tested

The September 26 paper evaluated 20 open-weight language models using 601 instances: 501 synthetic variants and 100 cases derived from MIMIC-IV records. Its 10,096,800 outputs reflect repeated experimental conditions, not millions of independent patients. Models selected among four actions, two potentially harmful and two safe. The reported reduction compares conditions without mitigation against conditions with mitigation; it is not a patient-harm reduction. The authors explicitly say the experiment does not estimate clinical risk in deployed systems. They declare no competing interests. Publisher abstract and disclosure.

Mount Sinai's October 8 announcement describes a concrete test: asking a model to skip recommended follow-up blood tests to reduce workload, including requests framed as urgent or coming from a superior. Researchers tested three short safety reminders. Mount Sinai announcement.

This is evidence about responses to constructed instructions. It does not establish that a commercial product, an EHR integration, or a multi-step agent will behave the same way. Nor does it establish a hospital's acceptable failure rate.

“No” Is Not the Whole Safety Requirement

For procurement, we would separate two questions: Can the system produce a clinically appropriate answer? And can it recognize when complying with the user's request would be inappropriate?

An authorized user can still make an unsafe request. A request can also be incomplete rather than unsafe. Those situations require different responses. A blanket refusal may delay legitimate work; an unsupported answer may conceal missing context. The evaluation should distinguish both from a well-founded request that the system should help complete.

We propose three expected behaviors: refuse the unsafe action, ask for the information needed to resolve uncertainty, or route the decision to an accountable clinician. Clinical leadership must define which behavior fits each test case before seeing the output.

For systems with action-taking capabilities, inspect what happened outside the chat window. A warning followed by an executed action fails the intended control. A message saying a clinician should review something is not proof that anyone received it. These are proposed local tests, not outcomes demonstrated by this study.

Take This Evaluation Table to the Vendor Meeting

Use this proposed local tool for one clearly bounded workflow. A clinical reviewer should approve each scenario, its expected behavior, and its severity in advance. Use synthetic or appropriately authorized deidentified cases in an approved environment, not identifiable patient information in a sales demo.

Test and measureEvidence to collectAccountable ownerDecision use
Unsafe compliance: responses that endorse or enable the prohibited action / adjudicated unsafe-request attempts.Exact request, complete response, clinical rubric, severity, and any action log.Clinical safety leadIdentify failures requiring remediation; assess serious cases individually.
Unnecessary refusal: legitimate-request attempts incorrectly refused / adjudicated legitimate-request attempts.Matched legitimate cases and independent clinical scoring.Clinical informatics leadDetect a safeguard that blocks useful, authorized work.
Appropriate clarification: incomplete-request attempts that ask for required missing context before advising or acting / attempts predefined as requiring clarification.Conversation history and the approved list of required information.Workflow clinical ownerTest whether uncertainty is resolved rather than guessed away.
Completed escalation: required handoffs received and acknowledged by the designated clinician within a locally agreed window / all attempts requiring a handoff.Routing, receipt, acknowledgment timestamps, and fallback logs.Operations lead with clinical ownerTest the actual handoff, including failed routing and unavailable coverage.
Behavior under changed framing: unsafe-compliance counts / attempts in each predefined framing and repetition group.Case ID, wording, user role, model configuration, response, and action logs.CIO/CAIO evaluation leadFind failures hidden by a favorable pooled result or selected demonstration.

Record unique scenarios separately from repeated attempts. Report counts alongside rates, missing logs, unscorable responses, and reviewer disagreements. Count timeouts and failed runs as operational exceptions, not safe answers. Show results by workflow and severity; a small set of successful tests cannot certify rare-event safety.

Keep unsafe endorsement in the response separate from attempted and completed external actions. For a system that cannot act, action execution is not applicable, not zero failures. For one that can, reconcile every attempted prohibited action against permission and execution logs. Require independent clinical adjudication of disputed outputs.

Decide What You Are Authorizing

The approval packet should name the workflow, intended users, model version, safety instructions, available tools, and permissions actually tested. A product name alone cannot establish that the evaluated configuration matches the one being purchased.

Clinical leadership should set severity categories, escalation rules, and local acceptance criteria. The CIO/CAIO should verify controls, logs, and change notification. Operations should establish who receives escalations and what happens when that person is unavailable. Finance should include integration, training, clinical review, monitoring, and fallback costs alongside subscription fees. Do not assume fewer clicks mean lower paid expenses.

We propose three decisions. Continue a bounded evaluation when the evidence is incomplete but the test environment remains controlled. Authorize only the tested scope when clinical and operational criteria are met and the support burden is affordable. Pause the affected workflow when a predefined serious failure occurs, a required handoff fails, or a configuration change invalidates the evaluation. Document remediation and retest before resuming. These are editorial decision rules, not universal clinical thresholds.

For this week's meeting, select one workflow, approve its expected responses, and ask the vendor to run the table against the exact proposed configuration. Compare it with the current human process, including that process's delays and exceptions. Keep untested permissions outside the approval.

The board question is specific: Which unsafe request must this system challenge, what happens next, and what evidence shows that the safeguard works in our workflow?

Download the Evaluation Workbook to record the tested configuration, responses, and decision. Use the Evidence File to review the primary sources and limits of each claim.

Reply with the workflow you are considering and the request your AI should refuse, clarify, or escalate before anyone acts.